Nrv-systemic

Nervouse System Aid

Vitality Works, Inc.
Human Otc Drug
NDC 64616-099

Nrv-systemic also known as Nervouse System Aid is a human otc drug labeled by 'Vitality Works, Inc.'. National Drug Code (NDC) number for Nrv-systemic is 64616-099. This drug is available in dosage form of Liquid. The names of the active, medicinal ingredients in Nrv-systemic drug includes Atropine - 14 [hp_X]/mL Causticum - 6 [hp_X]/mL Cinchona Officinalis Bark - 8 [hp_X]/mL Collinsonia Canadensis Root - 7 [hp_X]/mL Epinephrine - 20 [hp_X]/mL Krameria Lappacea Root - 10 [hp_X]/mL Ornithogalum Umbellatum - 10 [hp_X]/mL Pilocarpus Jaborandi Leaf - 7 [hp_X]/mL Potassium Arsenite Anhydrous - 18 [hp_X]/mL Sempervivum Tectorum Leaf - 10 [hp_X]/mL and more. The currest status of Nrv-systemic drug is Active.

Drug Information:

Drug NDC:	64616-099
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name:	Nrv-systemic
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type:	Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name:	Nervouse System Aid
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name:	Vitality Works, Inc.
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form:	Liquid
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status:	Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:	ATROPINE - 14 [hp_X]/mL CAUSTICUM - 6 [hp_X]/mL CINCHONA OFFICINALIS BARK - 8 [hp_X]/mL COLLINSONIA CANADENSIS ROOT - 7 [hp_X]/mL EPINEPHRINE - 20 [hp_X]/mL KRAMERIA LAPPACEA ROOT - 10 [hp_X]/mL ORNITHOGALUM UMBELLATUM - 10 [hp_X]/mL PILOCARPUS JABORANDI LEAF - 7 [hp_X]/mL POTASSIUM ARSENITE ANHYDROUS - 18 [hp_X]/mL SEMPERVIVUM TECTORUM LEAF - 10 [hp_X]/mL Load more... SILVER - 10 [hp_X]/mL SILVER IODIDE - 14 [hp_X]/mL SILVER NITRATE - 10 [hp_X]/mL THUJA OCCIDENTALIS LEAFY TWIG - 3 [hp_X]/mL ZINC - 20 [hp_X]/mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:	ORAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Marketing Category:	UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date:	08 Apr, 2013
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date:	22 Jun, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date:	31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Manufacturer Name:	Vitality Works, Inc.
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:	Yes
Whether or not the drug has been repackaged for distribution.
NUI:	N0000175574 N0000175370 N0000175700 N0000000125 N0000000209 N0000000245 N0000175552 N0000175555 N0000175570 M0003647
Unique identifier applied to a drug concept within the National Drug File Reference Terminology (NDF-RT).
UNII:	7C0697DR9I DD5FO1WKFU S003A158SB O2630F3XDR YKH834O4BH P29ZH1A35Z 9NS3M2Y78S 26ZE1BZ2US BM2U42PAKI 3DGJ7BUA01 Load more... 3M4G523W1G 81M6Z3D1XE 95IT3W8JZE 1NT28V9397 J41CSQ7QDS
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.
Pharmacologic Class MOA:	Cholinergic Antagonists [MoA] Cholinergic Muscarinic Antagonists [MoA] Adrenergic alpha-Agonists [MoA] Adrenergic beta-Agonists [MoA]
Mechanism of action of the drug—molecular, subcellular, or cellular functional activity—of the drug’s established pharmacologic class. Takes the form of the mechanism of action, followed by `[MoA]` (such as `Calcium Channel Antagonists [MoA]` or `Tumor Necrosis Factor Receptor Blocking Activity [MoA]`.
Pharmacologic Class EPC:	Anticholinergic [EPC] Cholinergic Muscarinic Antagonist [EPC] alpha-Adrenergic Agonist [EPC] beta-Adrenergic Agonist [EPC] Catecholamine [EPC]
Established pharmacologic class associated with an approved indication of an active moiety (generic drug) that the FDA has determined to be scientifically valid and clinically meaningful. Takes the form of the pharmacologic class, followed by `[EPC]` (such as `Thiazide Diuretic [EPC]` or `Tumor Necrosis Factor Blocker [EPC]`.
Pharmacologic Class CS:	Catecholamines [CS]
Chemical structure classification of the drug product’s pharmacologic class. Takes the form of the classification, followed by `[Chemical/Ingredient]` (such as `Thiazides [Chemical/Ingredient]` or `Antibodies, Monoclonal [Chemical/Ingredient].
Pharmacologic Class:	Adrenergic alpha-Agonists [MoA] Adrenergic beta-Agonists [MoA] Anticholinergic [EPC] Catecholamine [EPC] Catecholamines [CS] Cholinergic Antagonists [MoA] Cholinergic Muscarinic Antagonist [EPC] Cholinergic Muscarinic Antagonists [MoA] alpha-Adrenergic Agonist [EPC] beta-Adrenergic Agonist [EPC]
These are the reported pharmacological class categories corresponding to the SubstanceNames listed above.

Packaging Information:

Package NDC	Description	Marketing Start Date	Marketing End Date	Sample Available
64616-099-02	59 mL in 1 BOTTLE, DROPPER (64616-099-02)	08 Apr, 2013	N/A	No
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Other medicines with the same generic name

Nrv-systemic

Nervouse System Aid

Liquid
Vitality Works, Inc.
NDC: 64616-099

Purpose:

Nrv-systemic aids in balancing and stimulating the nervous system.

Product Elements:

Nrv-systemic nervouse system aid alcohol water epinephrine epinephrine silver iodide iodide ion silver silver silver nitrate silver cation atropine atropine causticum causticum cinchona officinalis bark cinchona officinalis bark collinsonia canadensis root collinsonia canadensis root potassium arsenite anhydrous arsenite ion ornithogalum umbellatum ornithogalum umbellatum pilocarpus jaborandi leaf pilocarpus jaborandi leaf krameria lappacea root krameria lappacea root sempervivum tectorum leaf sempervivum tectorum leaf thuja occidentalis leafy twig thuja occidentalis leafy twig zinc zinc

Indications and Usage:

Nrv-systemic for the temporary relief of muscular and joint pain and discomfort, dizziness, fatigue and anxiety.

Warnings:

Nrv-systemic use only under the direction of a health care professional. do not use if tamper evident seal is broken or missing.

Dosage and Administration:

Nrv-systemic orally 25 drops, 2 times per day or as indicated by a physician. children 12 and under use one half the adult dosage.

Package Label Principal Display Panel:

Nrv-systemic label

Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.